Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
about
Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanomaCan nanomedicines kill cancer stem cells?Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on PaclitaxelThe strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicityCurrent approaches to enhance CNS delivery of drugs across the brain barriersEffects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.P-glycoprotein and drug therapy in organ transplantation.Multilayer spheroids to quantify drug uptake and diffusion in 3D.ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosinCan multidrug resistance mechanisms be modified?Molecular pathways: regulation and therapeutic implications of multidrug resistancePharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation.Therapeutic ultrasound: its application in drug delivery.Polymorphisms in the ABC drug transporter gene MDR1.Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug ResistanceDoxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells.Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models.A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patientsRecurrent Male Breast Cancer Accompanied by Carcinomatous Pleuritis That Responded to Combination Therapy with High-Dose Toremifene and DocetaxelTrametinib modulates cancer multidrug resistance by targeting ABCB1 transporterImaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazineCyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.Scheduling of anticancer drugs: timing may be everything.MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cellsBioimaging real-time PXR-dependent mdr1a gene regulation in mdr1a.fLUC reporter mice.Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.A new model for studying tissue-specific mdr1a gene expression in vivo by live imagingThe reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsInfluence of melanosome dynamics on melanoma drug sensitivity.New strategies to deliver anticancer drugs to brain tumors.Discovery of novel antitumor antimitotic agents that also reverse tumor resistance.
P2860
Q24649754-392F7FCE-44F3-41BA-B0AF-F6A96B55D723Q27022017-48A625FD-8E25-4FF4-B65A-0D004D8D076EQ28361976-03B9FCA0-8A3B-4D95-B252-54C813423786Q28469350-69F3C142-400A-4795-B47E-7E6D5060021FQ28543104-1101E8D1-BF65-43A2-BEC2-1A016BAE194AQ30437835-564B8BD4-8D53-4AE2-A3A8-64C010ED07CEQ30475533-FC47B11E-3F2C-4FD3-AF36-9F2F3AA22386Q33490314-2E1A2479-5E31-4DF4-8FC3-55763204E057Q33559358-35BDAEC3-7EB8-4E36-BC9E-F1628F685A26Q33749785-22D20458-DEE1-4B41-8FB0-E96C9806F8FCQ33894623-DE640462-229B-40EE-8E5D-AA749D0429D2Q33938893-0C8AA044-67B5-4FED-AF92-936C032180FCQ34005841-58930548-806B-4501-9FC2-FBD2C6B08D8EQ34022485-5C6E68B7-63D4-4F6A-B4EC-7868106582CCQ34255292-5A78F4CD-2BF7-4080-937C-CC7FBFFF082AQ34303346-6AEF6CA6-EDBE-49D0-B2DD-8BF69014289AQ34540070-BBB8AAED-4284-4AF1-AF2E-7D943904EC0AQ34576932-DB490AA2-B2D9-48AF-A0BF-BE09FDC750B7Q34774854-B3A6F3CF-44D1-44B5-B844-6CCE7EB62928Q35025106-9609EC8F-7A22-47BD-AC3B-D72BFAEAD6E1Q35110635-9497B2AC-0A3A-4794-9909-4CD22CA230E3Q35164785-F2E86FD4-134C-4112-A423-9D7DB86AF8B9Q35205132-753D9D6A-F35D-4747-B7AA-032BDEE16312Q35415573-0A8E7298-82DC-4291-A86C-A4D0E08D39BCQ35547203-52B38BE6-3D77-47FC-9EF6-3D1903201AE8Q35644350-5173B7B3-23E9-4754-8312-86BB3DFD1007Q35803848-56A7AF76-0BF7-4CB5-B280-319926B92F6BQ35976130-6A6784BB-8015-4FB6-8786-040840BFFBCAQ36021057-390D88F8-2D60-4983-A5D5-41A26B7A7652Q36161579-12D09C76-18B7-4D59-BEA7-AFD0D59E57DAQ36489941-14C907C8-BEBE-4334-BE8A-50DFFA1A0F1BQ36556304-7A36B6EC-255A-44F1-9BCF-1C2A770BCC89Q36642262-60BE7481-3C06-446F-8E80-D98CA1D03DFAQ36852597-FED5A2F3-CB0A-4E26-8AF4-DDB75D77290AQ37028731-15637B67-FAB9-4E9F-BE0C-8D8B5F3E4D41Q37126122-B221CEE5-EDA2-48C8-A5BF-B53A4C56631FQ37289000-A9A4BFCB-68A4-49D0-9236-E138312361F2Q37348595-AA9F726B-C6B3-4B4B-BC52-16A5B5C54F88Q37364700-DAC65BD5-59D9-4933-A7B7-0950CC7A7FD0Q37380736-D4440584-1C87-46AB-94E3-2BBB6851A0FD
P2860
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
@en
type
label
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
@en
prefLabel
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
@en
P2093
P356
P1476
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
@en
P2093
G A Fisher
L Beketic-Oreskovic
P2888
P356
10.1007/S002800051055
P478
P577
1997-01-01T00:00:00Z
P5875
P6179
1051867318